News

Taro Pharmaceuticals has issued a recall notice for one lot of lamotrigine 100 mg tablets, as this lot was found to have been cross-contaminated with a small amount of Enalapril Maleate, a drug indicated for hypertension and congestive heart failure.

Mylan Pharmaceuticals Inc. is recalling one lot of alprazolam tablets due to the potential presence of foreign substance, which can cause infection.

After Sandoz Inc. voluntarily recalled all quantities and lots within expiry of ranitidine hydrochloride due to confirmed contamination of N-Nitrosodimethylamine (NDMA), a probable human carcinogen, three other major companies are recalling ranitidine hydrochloride as well for the same issue.

The FDA has approved Reyvow (lasmiditan) tablets for the acute treatment of migraine with or without aura in adults. This drug is not indicated for the preventive treatment of migraine and can cause driving impairment, which is why Reyvow is pending controlled substance scheduling.